Literature DB >> 1976113

Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract.

T Sareneva1, H Holthöfer, T K Korhonen.   

Abstract

Binding characteristics of the two major fimbrial hemagglutinin types of uropathogenic Proteus mirabilis were determined in frozen sections of human kidney and in exfoliated uroepithelial cells. P. mirabilis 3087, which expresses the MR/P fimbriae, adhered avidly to the tubular epithelial cells of the kidney and also to the epithelial cells of urinary sediment. No adhesion to glomerular or peritubular elements of the kidney was detected. Indirect immunogold silver staining also showed that the purified MR/P fimbriae recognized the same kidney domains. Adhesion of strain 3087 to uroepithelial cells was completely inhibited by Fab fragments of antibodies against the purified MR/P fimbriae. A completely different tissue-binding pattern was exhibited by the MR/K fimbriae of P. mirabilis 2456. In the kidney, the MR/K fimbriae bound strongly to the Bowman's capsule of the glomeruli and to the tubular basement membranes. A weak binding to glomerular mesangium and tubular epithelial cells was also seen. Strain 2456 did not adhere to epithelial cells of urinary sediment. Analysis of normal human urine showed that it contains low-molecular-weight molecules capable of inhibiting the binding of the MR/P fimbriae; no urinary inhibitors could be detected for the MR/K fimbriae. Poor in vivo binding capacity to intact human uroepithelial cells may be an important factor in explaining the relatively low pathogenicity of P. mirabilis in healthy hosts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976113      PMCID: PMC313658          DOI: 10.1128/iai.58.10.3330-3336.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

2.  Immobilizing antibodies in urine. II. Prevention of ascending spread of Proteus mirabilis.

Authors:  G J Pazin; A I Braude
Journal:  Invest Urol       Date:  1974-09

3.  [Ecology and significance of the Proteus group].

Authors:  E Tomaschoff
Journal:  Klin Wochenschr       Date:  1969-08-15

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Urease. The primary cause of infection-induced urinary stones.

Authors:  D P Griffith; D M Musher; C Itin
Journal:  Invest Urol       Date:  1976-03

6.  Urinary tract infections caused by Proteus mirabilis in children. The antibody response to O and H antigens and Tamm-Horsfall protein and bacterial adherence to uro-epithelium.

Authors:  P Larsson; A Fasth; U Jodal; A S Akerlund; C S Edén
Journal:  Acta Paediatr Scand       Date:  1978-09

7.  Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis.

Authors:  F J Silverblatt; I Ofek
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

8.  Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection.

Authors:  C S Edén; L A Hanson; U Jodal; U Lindberg; A S Akerlund
Journal:  Lancet       Date:  1976-09-04       Impact factor: 79.321

9.  A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.

Authors:  I TAMM; F L HORSFALL
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

10.  Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis.

Authors:  F J Silverblatt
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

2.  Proteus mirabilis ambient-temperature fimbriae: cloning and nucleotide sequence of the aft gene cluster.

Authors:  G Massad; J F Fulkerson; D C Watson; H L Mobley
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients.

Authors:  L M Loomes; B W Senior; M A Kerr
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 4.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

5.  Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection.

Authors:  F K Bahrani; D E Johnson; D Robbins; H L Mobley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Type 1 fimbriae of Salmonella enteritidis.

Authors:  K H Müller; S K Collinson; T J Trust; W W Kay
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

Review 7.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains.

Authors:  F K Bahrani; S Cook; R A Hull; G Massad; H L Mobley
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

9.  Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene.

Authors:  F K Bahrani; H L Mobley
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

Review 10.  Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.

Authors:  Chelsie E Armbruster; Harry L T Mobley
Journal:  Nat Rev Microbiol       Date:  2012-10-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.